NeueHealth to Host Second Quarter 2024 Earnings Conference Call on August 7, 2024
"Interest rate cuts + Trump's return" two major expectations continue to ferment! Will this benefiting sector see the dawn?
Market participants believe that in recent three years, the biotechnology sector has been underperforming the broader market. Once the expectation of interest rate cuts is raised by the Fed, biotechnology companies, represented by innovative drugs, will have the ability to make up ground.
Express News | Neuehealth Secures up to $150 Million in New Term Loan Facility With Hercules Capital
Express News | Neuehealth Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements
Analysts Conflicted on These Healthcare Names: NeueHealth Inc (NEUE), BridgeBio Pharma (BBIO) and Biohaven Ltd. (BHVN)
RBC Capital Sticks to Their Hold Rating for NeueHealth Inc (NEUE)
NeueHealth, Inc. (NYSE:NEUE) Q1 2024 Earnings Call Transcript
NeueHealth | 10-Q: Quarterly report
Earnings Call Summary | NeueHealth(NEUE.US) Q1 2024 Earnings Conference
NeueHealth, Inc. (NEUE) Q1 2024 Earnings Call Transcript
NeueHealth Inc (NEUE) (Q1 2024) Earnings Call Transcript Highlights: Insights and Strategic ...
Q1 2024 NeueHealth Inc Earnings Call
NeueHealth Inc's Annual Meeting Success and Director Elections
NeueHealth Q1 Revenue Drops
NeueHealth Expects 2024 Adjusted EBITDA Of $15M-$25M
NeueHealth's Forecasts 2024 Revenue Of Approximately $1B Versus Consensus Of $1.01B, With NeueCare Segment Revenue Of $310M-$320M And NeueSolutions Segment Revenue Of $690M-$700M
NeueHealth Q1 2024 GAAP EPS $(2.31) Beats $(3.50) Estimate, Sales $245.095M Miss $248.509M Estimate
Earnings Flash (NEUE) NEUEHEALTH Reports Q1 Revenue $245.1M
NeueHealth Sees FY24 Rev of About $1B >NEUE
NeueHealth Reports First Quarter 2024 Results
No Data